Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2022.862369
Abstract: Second-generation anti-amyloid monoclonal antibodies are emerging as a viable therapeutic option for individuals with prodromal and mild dementia due to Alzheimer's disease (AD). Passive immunotherapy with aducanumab (Aduhelm), lecanemab, donanemab, and gantenerumab all lower CNS… read more here.
Keywords: dementia due; due alzheimer; disease; aria ... See more keywords
Exploring the Alterations in the Distribution of Neural Network Weights in Dementia Due to Alzheimer’s Disease
Sign Up to like & getrecommendations! Published in 2021 at "Entropy"
DOI: 10.3390/e23050500
Abstract: Alzheimer’s disease (AD) is a neurodegenerative disorder which has become an outstanding social problem. The main objective of this study was to evaluate the alterations that dementia due to AD elicits in the distribution of… read more here.
Keywords: network weights; alzheimer disease; dementia due; distribution ... See more keywords